[Bleomycin in Hodgkin's disease (stages III and IV) and other lymphomas].
D001761:Bleomycin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D004341:Drug Evaluation; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007273:Injections, Intramuscular; D013997:Time Factors
D001761:Bleomycin
Efeitos do uso da bleomicina na moléstia de Hodgkin (Estádios III e IV) e outros linfomas